Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages - PubMed (original) (raw)

Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages

D Niederwieser et al. Transplantation. 1990 Oct.

Abstract

Serum levels of interferon-gamma and the IFN-dependent marker molecules neopterin and beta 2-microglobulin were assessed in BMT recipients. Concentrations of the latter two markers were corrected for creatinine levels in order to eliminate the impact of alteration of kidney function. Serum levels were assessed daily using commercially available radioimmunoassays. Twelve patients were studied during the early phase of allogeneic bone marrow transplantation and eleven additional patients during complications of BMT. Results indicated that both the conditioning regimen for BMT as well as major clinical complications such as infection and acute graft-versus-host disease strongly influence the endogenous patterns of the lymphokine and its secondary messages. During allogeneic BMT IFN-gamma and neopterin levels exhibited a biphasic pattern with a first peak during conditioning with high-dose cyclophosphamide and a second still higher peak at the time of hemopoietic regeneration. beta-2-microglobulin ratios increased during conditioning and remained elevated throughout observation. Serious infections of bacterial and viral origin as well as GvHD were accompanied by elevated levels of all three serum parameters studied. The kinetics of enhanced endogenous production, however, differed between infectious complications and GvHD. Increasing concentrations were observed during infections subsequent to clinical manifestation, whereas they preceded disease manifestation in GvHD.

PubMed Disclaimer

Cited by

Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation.
Scholl S, Sayer HG, Mügge LO, Kasper C, Pietraszczyk M, Kliche KO, Clement JH, Höffken K. Scholl S, et al. J Cancer Res Clin Oncol. 2004 Dec;130(12):704-10. doi: 10.1007/s00432-004-0603-6. Epub 2004 Sep 7. J Cancer Res Clin Oncol. 2004. PMID: 15365821
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.
Blaser BW, Schwind NR, Karol S, Chang D, Shin S, Roychowdhury S, Becknell B, Ferketich AK, Kusewitt DF, Blazar BR, Caligiuri MA. Blaser BW, et al. Blood. 2006 Oct 1;108(7):2463-9. doi: 10.1182/blood-2006-04-019059. Epub 2006 Jun 6. Blood. 2006. PMID: 16757683 Free PMC article.
An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.
Asavaroengchai W, Wang H, Wang S, Wang L, Bronson R, Sykes M, Yang YG. Asavaroengchai W, et al. Biol Blood Marrow Transplant. 2007 Jan;13(1):46-55. doi: 10.1016/j.bbmt.2006.09.014. Biol Blood Marrow Transplant. 2007. PMID: 17222752 Free PMC article.
KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
Boudreau JE, Giglio F, Gooley TA, Stevenson PA, Le Luduec JB, Shaffer BC, Rajalingam R, Hou L, Hurley CK, Noreen H, Reed EF, Yu N, Vierra-Green C, Haagenson M, Malkki M, Petersdorf EW, Spellman S, Hsu KC. Boudreau JE, et al. J Clin Oncol. 2017 Jul 10;35(20):2268-2278. doi: 10.1200/JCO.2016.70.7059. Epub 2017 May 18. J Clin Oncol. 2017. PMID: 28520526 Free PMC article.
Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
Nestel FP, Price KS, Seemayer TA, Lapp WS. Nestel FP, et al. J Exp Med. 1992 Feb 1;175(2):405-13. doi: 10.1084/jem.175.2.405. J Exp Med. 1992. PMID: 1732411 Free PMC article.

Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages - PubMed (original) (raw)